Reading Time: < 1 minutePlease help spread the word about these recent articles highlighting the Best Practices and Contemporary Approaches to Nonclinical Pathology Evaluation of Medical Devices!
Nonclinical Pathology Evaluation of Medical Devices? Read More »
Reading Time: 2 minutesExperimental Pathology Laboratories (EPL) welcomes Dr. Elizabeth Galbreath as Senior Pathologist and Manager of EPL-Boston. A board-certified veterinary pathologist with more than 25 years in biopharmaceutical research and development, Dr. Galbreath brings extensive expertise in toxicologic and investigative pathology, neuropathology, pathology peer review, and preclinical development strategy for complex biotherapeutic and gene therapy programs.
Elizabeth J. Galbreath, DVM, PhD, DACVP – Senior Pathologist, Manager EPL-Boston, MA Read More »
Reading Time: 4 minutesImmunohistochemistry or Immunofluorescence (IHC/IF) is employed routinely for investigative and diagnostic evaluations of antigen-antibody interactions within cells or tissues. While most IHC/IF target antigens are proteins, other antigenic biological substrates can also be recognized by antibodies (e.g., carbohydrates, lipids, or nucleic acids). Accurate and reproducible results are achieved when procedures used to identify and localize
Immunostaining Assay Optimization – Tackling Intrinsic Study Variables Read More »
Reading Time: 2 minutesWith the processing of up to 50,000 tissues per month, and projects regularly flowing in and out of our labs, histology scheduling at EPL is a continual process. Recognizing that the project timeline, in addition to quality and expertise, is one of the most important factors to our clients, we’re providing the following tips on the items
How to Ensure the Quickest Possible Histology Project Timeline Read More »
Reading Time: 3 minutesExperimental Pathology Laboratories, Inc. (EPL) meets or exceeds current FDA guidelines following the release of “Pathology Peer Review in Nonclinical Studies: Questions and Answers, Guidance for Industry” document in December 2021 (https://www.fda.gov/media/129533/download) At EPL we pride ourselves on providing our clients with not only the best services possible, but also with the up to the
Pathology Peer Review Read More »
Reading Time: 3 minutesMeet EPL and Aclairo at the 38th Annual ACT in Booth #200 Members of EPL, Inc. and Aclairo Pharmaceutical Development Group, Inc. will attend the 2017 38th Annual meeting of the American College of Toxicology held at the Palm Springs Convention Center – 277 N. Avenida Caballeros –Palm Springs, CA 92262. Register for ACT Join EPL at Our Hosted Program: “All About
Meet EPL and Aclairo at the 38th Annual ACT in Booth #200 Read More »
Reading Time: < 1 minuteMeet the professionals from EPL and Aclairo at the SOT 57th Annual Meeting and ToxExpo in San Antonio, Texas from March 11-15 in Booth #922. Register Now https://gallery.mailchimp.com/ac4f9b280cf9318f92a974f7f/images/2bae830e-b513-490d-b566-0d81955f4d5a.png https://gallery.mailchimp.com/ac4f9b280cf9318f92a974f7f/images/ddd85845-8d13-4be5-8019-c58db4a108b9.png About EPLFounded in 1971, Experimental Pathology Laboratories, Inc. (EPL®) is a private, employee-owned U.S. company that is recognized internationally for its ability to meet the needs of the scientific community and the
Meet EPL and Aclairo at the SOT 57th Annual Meeting Read More »
Reading Time: < 1 minuteExperimental Pathology Laboratories, Inc. (EPL) announces a new strategic alliance with Quality Scientific Solutions, LLC (QS3). This alliance is targeted to provide EPL’s preclinical pathology expertise as an important resource to QS3. About Quality Scientific SolutionsQuality Scientific Solutions, LLC is a research and consulting company dedicated to helping clients create products that meet the highest standard
Reading Time: 2 minutesExperimental Pathology Laboratories, Inc. (EPL) is an independent, private, employee-owned company that is recognized internationally for its ability to meet the needs of the scientific community and the challenges of preclinical safety testing and development with high quality histopathology services. EPL was founded in 1971, and became an employee-owned company in 1992. EPL is proud
EPL – Independent and Employee-Owned Read More »
Reading Time: 2 minutesExperimental Pathology Laboratories, Inc. (EPL) and Aclairo Pharmaceutical Development Group, Inc. (Aclairo) are excited to announce that Dr. Heath Thomas has joined Aclairo as President and Senior Consultant. Dr. Thomas is a board-certified veterinary pathologist with over 20 years of experience in drug development from time spent with SmithKline Beecham, DuPont Pharmaceuticals, and GlaxoSmithKline, as
Aclairo Welcomes Dr. Heath Thomas as New President Read More »
